Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
TaiGen Successfully Completes TG-1000 Phase III Study 2024-04-18 11:03
TaiGen Enters Exclusive License Agreement with YSP 2023-10-11 11:24
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R) 2020-11-09 18:22
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand 2020-09-30 15:51
TaiGen Biotechnology Announces Submission of New Drug Application for Taigexyn® Intravenous Formulation to the China Food and Drug Administration 2017-05-30 13:15
1